Search for: [Abstract = "er PCI and 2 \(1.6%\) MIs, Following successful PCI, symptom reduction by at least one CCS class was seen in 101 \(80.2%\) pts, including all pts treated in the course of acute coronary syndrome \(ACS\). In the long\-term follow up of 2.5 years \(range 1\-63 months\), MACE occurred in 54 out of 127 pts subjected to PCI. There were 9 deaths, including 5 cardiac deaths. Due to symptom recurrence, another angiography was performed in 44 pts. This revealed restenosis in 26 pts, atherosclerosis progression in 10 pts, and both causes in 2 pts. In 27 pts rePCI was performed, 3 pts were referred for reCABG and 2 for cardiac transplantation. After successful PCI, MACE\-free survival was noted in 81% pts at 1 year and 65% at 5 years. The likelihood of MACE\-free survival was higher for those after nv\-PCI as compared to svg\-PCI \(p=0.047\). There was no difference in MACE\-free survival for those with PCI in stable angina vs. ACS \(89.2 vs. 93.6% at 6 months, 71.9 vs. 62.5% at 2 years\). Among the 127 pts subjected to successful PCI, 64 \(50.4%\) had hs\-CRP ≥ 3.5mg\/dl and 47 \(37%\) fibrinogen >3.5 g\/L. No relationship was revealed between non\-specific inflammatory markers elevation \(including hs\-CRP\) and the risk of MACE. Patients with elevated IgA or IgG against ChP had a higher risk of MACE \(particularly death\) \(p=0.047 and p=0.045 respectively\). To determine independent predictors of long\-term MACE, 44 pa"]
